Glucose Metabolism Disorders: all 361 studies
Page 4 of 4. Open to participants first (38), then studies with results posted, then the rest; newest registration first within each.
- Closing the Loop 24/7 in Adolescents With Type 1 DiabetesCompletedNCT01873066Not applicable
- The Physical Activity and Nutrition in Children (PANIC) StudyStatus unknownNCT01803776Not applicable
- DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and IbuprofenCompletedNCT01785108Phase 2
- Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home SettingCompletedNCT01778348Phase 2
- Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese SubjectsCompletedNCT01757756Phase 1
- Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee ReplacementTerminatedNCT01743313
- Effect of Age on Glucose and Lipid MetabolismCompletedNCT01737164Not applicable
- Lean Seafood Intake and Postprandial MetabolismCompletedNCT01708681Not applicable
- OPTIFIT-Optimal Fiber Trial for Diabetes PreventionCompletedNCT01681173Not applicable
- Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic PatientsStatus unknownNCT01662193Not applicable
- Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa VillageStatus unknownNCT01535105
- Endotoxin & Cytokines. Do Protein Loss and Metabolic Effects Depend on Central Nervous System (CNS) Activation of Stress Hormones or on Local Mechanisms in Muscle and Fat?CompletedNCT01452958Not applicable
- Prospective Follow-up of a Cohort of Pre-diabetics in the North of France (DiabeNord)CompletedNCT01432509Not applicable
- Cirrhosis-DiabetesStatus unknownNCT01396954
- A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
- Effects of Alogliptin on Pancreatic Beta Cell FunctionStatus unknownNCT01303055Not applicable
- DEMOJUAN- DEMOnstration Area for Primary Prevention of Type 2 Diabetes, JUAN Mina and Barranquilla, ColombiaCompletedNCT01296100Not applicable
- Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes MedicationCompletedNCT01293578Not applicable
- Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes MellitusCompletedNCT01261494Phase 2
- Multiple Dose Study of PF-04991532 in Patients With Type 2 DiabetesCompletedNCT01129258Phase 1
- Single Dose Study of PF-04991532 in Healthy SubjectsCompletedNCT01102673Phase 1
- Balance System Study in Type 2 Diabetic PatientsCompletedNCT00872846Phase 1
- Sleep and Obesity in TeenagersCompletedNCT00841347Not applicable
- Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCompletedNCT00772174Phase 3
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
- Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.CompletedNCT00770835Phase 4
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
- Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.CompletedNCT00770445Phase 4
- Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00763347Phase 2
- Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00763022Phase 3
- Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
- Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00762736Phase 2
- Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762684Phase 3
- Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762190Phase 3
- Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762112Phase 3
- Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00760344Phase 2
- Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TerminatedNCT00759720Phase 3
- Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCompletedNCT00754403Phase 4
- Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTerminatedNCT00722917Phase 2
- Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With InsulinCompletedNCT00676260Phase 2
- Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.CompletedNCT00672919Phase 4
- Efficacy of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00653185Phase 2
- Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
- Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
- Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4
- One Year Glargine Treatment in CFRD Children and AdolescentsCompletedNCT00483769Phase 4
- Accuracy and Safety of Real Time Continuous Glucose Monitoring Before, During and After SurgeryCompletedNCT00464529
- Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.CompletedNCT00449553
- Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOCompletedNCT00362323Phase 3
- Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedNCT00361868Phase 3
- Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesCompletedNCT00349128Phase 2/3
- Acceptability of a Fixed Combination of Fenofibrate and MetforminCompletedNCT00348725Phase 3
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
- Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.CompletedNCT00225264Phase 3
- Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3
- Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsCompletedNCT00192621Phase 4
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3
- The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood GlucoseCompletedNCT00114855Not applicable
- Effects of Insulin Sensitizers in Subjects With Impaired Glucose ToleranceCompletedNCT00108615Phase 4
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3